ArticleJournal of nanobiotechnology2026

Bioengineered anti-EpCAM-guided exosome nanocarriers delivering Foxp3 agonist butyrate achieve tissue-specific immunomodulation in autoimmune Sjögren's syndrome.

Bailing Tian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.